Adma Biologics Inc
About
7.98USD+0.05 +0.63%
Closed • Updated at 04:45 GMT+00:00Market Cap$1.85B
P/E Ratio11.77
Volume3.10M
Beta1.18
RSI31.16
Gross Margin61.24%
Adma Biologics Inc — investor relations, events, news, and company updates on 6ix.
Latest News
May 6 2026
ADMA Biologics Reports First Quarter 2026 Financial Results and Provides Business Update
May 4 2026
ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older
Apr 29 2026
ADMA Biologics to Report First Quarter 2026 Financial Results on May 6, 2026
Mar 27 2026
ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper Research
Mar 25 2026
ADMA Biologics Addresses Misleading Short-Seller Report
Recent Videos
ADMA Biologics: Um motor de crescimento no Russell 2000
May 16, 2026
Adma Biologics Inc. 2026 quarterly report
May 12, 2026
ADMA Biologics $ADMA Stock Review
May 03, 2026
ADMA STOCK : POTENTIAL RECOVERY | ADMA BIOLOGICS STOCK
Apr 28, 2026
Community Chat
Ask AI
Try asking